Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6‐month follow‐up from US real‐world data

AIM: To compare 6‐month adherence, persistence and treatment patterns among patients initiating once‐weekly glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), dulaglutide versus semaglutide, and dulaglutide versus exenatide BCise, using claims from the HealthCore Integrated Research Database. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Reema, Yu, Maria, Nepal, Bal, Konig, Manige, Grabner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756843/
https://www.ncbi.nlm.nih.gov/pubmed/32945083
http://dx.doi.org/10.1111/dom.14195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756843/
https://www.ncbi.nlm.nih.gov/pubmed/32945083
http://dx.doi.org/10.1111/dom.14195

Ejemplares similares